GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BiOptic Inc (ROCO:6850) » Definitions » Interest Coverage

BiOptic (ROCO:6850) Interest Coverage : 25.13 (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is BiOptic Interest Coverage?

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. BiOptic's Operating Income for the six months ended in Dec. 2023 was NT$26.3 Mil. BiOptic's Interest Expense for the six months ended in Dec. 2023 was NT$-1.0 Mil. BiOptic's interest coverage for the quarter that ended in Dec. 2023 was 25.13. The higher the ratio, the stronger the company's financial strength is.

The historical rank and industry rank for BiOptic's Interest Coverage or its related term are showing as below:

ROCO:6850' s Interest Coverage Range Over the Past 10 Years
Min: 2.95   Med: 33.04   Max: 227.29
Current: 33.04


ROCO:6850's Interest Coverage is ranked worse than
64.35% of 345 companies
in the Biotechnology industry
Industry Median: 144.99 vs ROCO:6850: 33.04

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


BiOptic Interest Coverage Historical Data

The historical data trend for BiOptic's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

BiOptic Interest Coverage Chart

BiOptic Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Interest Coverage
Get a 7-Day Free Trial 2.95 26.39 72.99 227.29 33.04

BiOptic Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Interest Coverage Get a 7-Day Free Trial Premium Member Only Premium Member Only 313.51 262.70 213.54 60.83 25.13

Competitive Comparison of BiOptic's Interest Coverage

For the Biotechnology subindustry, BiOptic's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BiOptic's Interest Coverage Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BiOptic's Interest Coverage distribution charts can be found below:

* The bar in red indicates where BiOptic's Interest Coverage falls into.



BiOptic Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

BiOptic's Interest Coverage for the fiscal year that ended in Dec. 2023 is calculated as

Here, for the fiscal year that ended in Dec. 2023, BiOptic's Interest Expense was NT$-1.3 Mil. Its Operating Income was NT$44.4 Mil. And its Long-Term Debt & Capital Lease Obligation was NT$85.8 Mil.

Interest Coverage=-1* Operating Income (A: Dec. 2023 )/Interest Expense (A: Dec. 2023 )
=-1*44.412/-1.344
=33.04

BiOptic's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Here, for the six months ended in Dec. 2023, BiOptic's Interest Expense was NT$-1.0 Mil. Its Operating Income was NT$26.3 Mil. And its Long-Term Debt & Capital Lease Obligation was NT$85.8 Mil.

Interest Coverage=-1* Operating Income (Q: Dec. 2023 )/Interest Expense (Q: Dec. 2023 )
=-1*26.286/-1.046
=25.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.


BiOptic  (ROCO:6850) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .


BiOptic Interest Coverage Related Terms

Thank you for viewing the detailed overview of BiOptic's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.


BiOptic (ROCO:6850) Business Description

Traded in Other Exchanges
N/A
Address
No 6, Ln, 130 Minquan Road, 5th Floor, Hsin- Tien District, New Taipei, TWN, 23141
BiOptic Inc is a biotechnology instrumentation company that develops innovative scientific products for research and clinical applications. It serves professionals and laboratories dedicated to life science research, clinical diagnostics, pharmaceutical and food industries, animal husbandry and agriculture, performing diagnostic molecular genetic analyses.

BiOptic (ROCO:6850) Headlines

No Headlines